Stock screenerAll disclosures →
EDGAR →
KTTA
Conviction 8HealthcareScan · Thu, Jun 25, 2026KTTA$0.5392-3.00%
ResistanceSupportVol 14Insider buyVol MA14 315.24K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price0.5392
Change-3.00%
Gap-0.32%
Rel volume0.76×
Avg volume508.15K
Avg $ vol316.62K
SMA 200.5911
SMA 500.6847
SMA 2000.8009
Price vs 50-21.25%
Price vs 200-32.68%
MA stackbearish
50/200 cross—
Supertrenddown · 0.6500
RSI (14)36
MACD hist0.00
MACD crossbull · 1d
Stoch %K / %D38 / 43
ADX (14)29
+DI / −DI19 / 24
RSI divergence—
MACD divergenceBullish
ATR %+9.34%
ADR %8.63%
52w high1.47
52w low0.2923
From 52w high-63.32%
Above 52w low+84.47%
New 52w highNo
SqueezeOff
Bollinger width42.61%
%B0.29
Donchian pos19.42%
Donchian high0.7429
Donchian low0.4901
AVWAP (52w high)1.41
vs AVWAP high-61.82%
AVWAP (52w low)1.10
vs AVWAP low-50.80%
OBV trendDown
Chaikin MF (20)-0.22
Today vs 20d0.76×
Avg vol (14d)315.24K
Avg vol (20d)508.15K
Avg $ vol (20d)316.62K
Market cap18.02M
RS 3m (vs SPY)-39.67%
RS 6m (vs SPY)-59.81%
RS line new highNo
Trend template2/8
Technical rank10.4
1 week+7.35%
1 month-20.72%
3 months-30.99%
6 months-54.31%
1 year-26.24%
YTD-54.69%
P/E-0.88
P/B0.33
P/S37.03
P/FCF-1.18
EPS-2.91
Div yield—
ROE-37.27%
ROA-36.25%
Debt/Eq—
Current35.40
EV/EBITDA—
Gross margin-0.45%
Net margin—
Rev growth3130.37%
EPS growth-46.91%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-32.38M
Revenue218.61K
Net income-2.87M
Gross profit132.14K
Free cash flow-15.25M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out24.94M
Employees5
ListedWed, Sep 15, 2021
Free float20.26M
Float %81.2%
Short interest274.58K
Days to cover0.6d
Short volume51.3%
Squeeze score13 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction8 / 100
Pattern quality—
Tech rank10.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.8888
Support0.5155
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KTTA
No recent disclosed trades by Congress in KTTA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in KTTA · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Coastlands Capital LP 10% owner · Common Stock · 2026-06-17 | Buy | 100K | $53K | 2026-06-17 | 2026-06-22 |
Novak Alfred J Director · Stock Option (right to buy) · 2026-05-01 | Grant | 152.78K | $0 | 2026-05-01 | 2026-05-05 |
Dumesnil Simon Director · Stock Option (right to buy) · 2026-05-01 | Grant | 152.78K | $0 | 2026-05-01 | 2026-05-05 |
Marques Tiago Chief Executive Officer · Stock Option (right to buy) · 2026-05-01 | Grant | 1.76M | $0 | 2026-05-01 | 2026-05-05 |
Leahy Emer Director · Stock Option (right to buy) · 2026-05-01 | Grant | 152.78K | $0 | 2026-05-01 | 2026-05-05 |
Schneiderman Daniel H Chief Financial Officer · Stock Option (right to buy) · 2026-05-01 | Grant | 1.13M | $0 | 2026-05-01 | 2026-05-05 |
Krishnan Kartik Chief Medical Officer · Stock Option (right to buy) · 2026-05-01 | Grant | 1.13M | $0 | 2026-05-01 | 2026-05-05 |
STEINMAN LAWRENCE Director · Stock Option (right to buy) · 2026-05-01 | Grant | 152.78K | $0 | 2026-05-01 | 2026-05-05 |
SEC filings
EDGAR filings in KTTA · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.